First Time Loading...
S

Samjin Pharmaceutical Co Ltd
KRX:005500

Watchlist Manager
Samjin Pharmaceutical Co Ltd
KRX:005500
Watchlist
Price: 19 140 KRW -0.31% Market Closed
Updated: Jun 1, 2024

Samjin Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Samjin Pharmaceutical Co Ltd
Revenue Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Samjin Pharmaceutical Co Ltd
KRX:005500
Revenue
₩294.7B
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
4%
Yuhan Corp
KRX:000100
Revenue
₩1.9T
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
7%
SK Biopharmaceuticals Co Ltd
KRX:326030
Revenue
₩354.9B
CAGR 3-Years
139%
CAGR 5-Years
218%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Revenue
₩1.5T
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
7%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Revenue
₩197B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
6%
C
Celltrion Pharm Inc
KOSDAQ:068760
Revenue
₩395.8B
CAGR 3-Years
13%
CAGR 5-Years
20%
CAGR 10-Years
23%

See Also

What is Samjin Pharmaceutical Co Ltd's Revenue?
Revenue
294.7B KRW

Based on the financial report for Mar 31, 2024, Samjin Pharmaceutical Co Ltd's Revenue amounts to 294.7B KRW.

What is Samjin Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
4%

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Samjin Pharmaceutical Co Ltd have been 8% over the past three years , 3% over the past five years , and 4% over the past ten years .